The United States, the worst-affected nation globally with the novel Coronavirus outbreak has started the vaccination program to vaccinate the public has started earlier in December, last year.
As part of the vaccination drive, a Mexican doctor who received the Pfizer-BioNTech COVID-19 vaccine reportedly developed seizures and other symptoms and was hospitalized.
According to the reports, the Mexican authorities have confirmed the development and said, they are examining the case of the doctor on why she developed symptoms.
After the doctor faced symptoms like seizures, skin rash, and difficulties in taking a breath she was said to be admitted to the Intensive Care Unit(ICU) unit a hospital in Nuevo Leon state.
The Mexican Health Ministry is said to have confirmed the condition of a 32-year-old doctor Encephalomyelitis, which is a condition of inflammation of the brain and spinal cord.
However, it is said that the doctor has a history of allergic reactions, which is why she developed symptoms of seizures, skin rash, and difficulties in taking a breath.
The Health Ministry went on to say that no allergic reactions were reported so far and the clinical trial and the vaccination program didnât report any such inflammation.
As part of the vaccination drive, a Mexican doctor who received the Pfizer-BioNTech COVID-19 vaccine reportedly developed seizures and other symptoms and was hospitalized.
According to the reports, the Mexican authorities have confirmed the development and said, they are examining the case of the doctor on why she developed symptoms.
After the doctor faced symptoms like seizures, skin rash, and difficulties in taking a breath she was said to be admitted to the Intensive Care Unit(ICU) unit a hospital in Nuevo Leon state.
The Mexican Health Ministry is said to have confirmed the condition of a 32-year-old doctor Encephalomyelitis, which is a condition of inflammation of the brain and spinal cord.
However, it is said that the doctor has a history of allergic reactions, which is why she developed symptoms of seizures, skin rash, and difficulties in taking a breath.
The Health Ministry went on to say that no allergic reactions were reported so far and the clinical trial and the vaccination program didnât report any such inflammation.